郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Strategies to prevent cleavage of the linker region between ligand-binding repeats 4 and 5 of the LDL receptor.

期刊：Human molecular genetics发表年份：2019作者：Thea Bismo Strøm; Katrine Bjune; Luís Teixeira da Costa; Trond P Leren
阅读更多 →

药效评价Integrated in silico and in vitro genotoxicity assessment of thirteen data-poor substances.

期刊：Regulatory toxicology and pharmacology : RTP发表年份：2019作者：Yen K Tran; Julie K Buick; Jennifer L A Keir; Andrew Williams; Carol D Swartz; Leslie Recio; Paul A White; Iain B Lambert; Carole L Yauk
阅读更多 →

药效评价Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.

期刊：European journal of medicinal chemistry发表年份：2019作者：Feng Gao; Zijian Chen; Long Ma; Yilei Fan; Linjun Chen; Guangming Lu
阅读更多 →

药效评价The amidated PACAP1-23 fragment is a potent reduced-size neuroprotective agent.

期刊：Biochimica et biophysica acta. General subjects发表年份：2019作者：A Lamine; M Poujol de Molliens; M Létourneau; T E Hébert; D Vaudry; A Fournier; D Chatenet
阅读更多 →